Antares Pharma reported $65.91M in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Abbvie ABBV:US $ 6098M 3648M
Adma Biologics ADMA:US $ 69.5M 18.42M
Aerie Pharmaceuticals AERI:US $ 56.44M 19.25M
Ani Pharmaceuticals ANIP:US $ 76.91M 23.39M
Atrion ATRI:US 32.26M 8.61M
Becton, Dickinson and BDX:US $ 3147M 1244M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Cerus CERS:US $ 38.37M 10.39M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Endo International Ordinary Shares ENDP:US $ 1413.15M 94.05M
Horizon Pharma HZNP:US $ 1643.13M 62.81M
Meridian Bioscience VIVO:US $ 1.02M 0M
Orasure Technologies OSUR:US $ 70.72M 46.04M
Pacira Pharmaceuticals PCRX:US $ 226.75M 358.83M
Pfizer PFE:US $ 2470M 526M
Revance Therapeutics RVNC:US $ 198.36M 87.74M
Sientra SIEN:US $ 38.88M 12.89M
Staar Surgical STAA:US $ 193.07M 6.64M
Supernus Pharmaceuticals SUPN:US $ 115.72M 87.72M
Teva Pharmaceutical TEVA:IT 2.18B 10M
Teva Pharmaceutical Industries TEVA:US $ 2175M 10M
Utah Medical Products UTMD:US $ 64.32M 8.29M